-transparent.png){kind=logo}
Cellular immunological reactivity was examined in 20 patients having melanomalignoma at different clinical stages, using Leukocyte-Migration-Inhibition-Test. As antigens three homologous melanoma-extracts were used, produced by our own method. Independent from the clinical stages cell-migration inhibition could be established in 15 out of the 20 patients. In this way, these tumor extracts have been shown to contain melanoma-associated antigens. Regardless of the clinical stage of the disease, the melanomalignomas patient produces cellular immunity against those tumor-antigens. It is note-worthy that the actual course of the disease seems not to be influenced by immun-mechanisms.
J Fritz, and
K Grond, and
G P Tilz
January 1979,
Infection,
J Fritz, and
K Grond, and
G P Tilz
September 1974,
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
J Fritz, and
K Grond, and
G P Tilz
November 1978,
Kekkaku : [Tuberculosis],
J Fritz, and
K Grond, and
G P Tilz
April 1978,
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
J Fritz, and
K Grond, and
G P Tilz
May 1977,
Klinische Monatsblatter fur Augenheilkunde,
J Fritz, and
K Grond, and
G P Tilz
April 1973,
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
J Fritz, and
K Grond, and
G P Tilz
November 1979,
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
J Fritz, and
K Grond, and
G P Tilz
November 1980,
Neurochirurgia,
J Fritz, and
K Grond, and
G P Tilz
November 1979,
Rinsho byori. The Japanese journal of clinical pathology,
J Fritz, and
K Grond, and
G P Tilz
January 1977,
Annales de dermatologie et de venereologie,
